Skip to main content
Back

Chapter 18: Practical Applications of Immunology – Vaccines and Immunological Diagnostics

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Chapter 18: Practical Applications of Immunology

History of Vaccination and Variolation

Vaccination and variolation are foundational practices in immunology, aimed at preventing infectious diseases by stimulating the immune system.

  • Variolation: An early method of immunization involving the deliberate introduction of material from smallpox sores into the skin, used before the development of modern vaccines.

  • Vaccination: Introduced by Edward Jenner in 1796, using cowpox virus to confer immunity to smallpox, leading to the development of safer and more effective vaccines.

  • Impact: Vaccination has led to the eradication or control of many infectious diseases, such as smallpox and polio.

Vaccination and Immune Response

Vaccines exploit the body's natural immune response to provide protection against pathogens.

  • Primary Immune Response: The initial response to an antigen, characterized by a lag phase and the production of IgM antibodies, followed by IgG.

  • Secondary Immune Response: Upon re-exposure to the same antigen, the immune system responds more rapidly and robustly, primarily with IgG antibodies, due to memory cells.

  • Effect of Vaccination: Vaccines mimic infection, inducing memory cells and preparing the immune system for future exposures.

Herd Immunity

Herd immunity refers to the indirect protection from infectious diseases that occurs when a large percentage of a population becomes immune.

  • Definition: When enough individuals are immune, the spread of contagious disease is minimized, protecting those who are not immune.

  • Public Health Implications: Achieving herd immunity through vaccination can prevent outbreaks and protect vulnerable populations (e.g., infants, immunocompromised individuals).

Types of Vaccines

Vaccines are classified based on their composition and method of preparation, each with specific advantages and disadvantages.

  • Live Attenuated Vaccines: Contain weakened forms of the pathogen that replicate in the host without causing disease in healthy individuals.

    • Advantages: Strong, long-lasting immunity; often requires fewer doses.

    • Disadvantages: Risk of reversion to virulence; not suitable for immunocompromised individuals.

    • Examples: Measles, mumps, rubella (MMR) vaccine.

  • Inactivated (Killed) Vaccines: Contain pathogens that have been killed by heat or chemicals.

    • Advantages: Cannot cause disease; safer for immunocompromised individuals.

    • Disadvantages: Weaker immune response; may require booster shots.

    • Examples: Inactivated polio vaccine (IPV).

  • Subunit Vaccines: Contain only specific antigens from the pathogen.

    • Recombinant DNA Vaccines: Antigens produced by genetic engineering.

    • Virus-like Particle (VLP) Vaccines: Mimic the structure of viruses but lack genetic material.

    • Toxoid Vaccines: Contain inactivated toxins (toxoids) produced by bacteria.

    • Advantages: Fewer side effects; focused immune response.

    • Disadvantages: May require adjuvants and booster doses.

    • Examples: Hepatitis B (recombinant), HPV (VLP), DTaP (toxoid).

  • Conjugated Vaccines: Polysaccharide antigens linked to proteins to enhance immunogenicity, especially in young children.

    • Example: Haemophilus influenzae type b (Hib) vaccine.

  • Nucleic Acid Vaccines: Use DNA or mRNA encoding the antigen to induce an immune response.

    • Advantages: Rapid development; strong cellular and humoral immunity.

    • Examples: COVID-19 mRNA vaccines (Pfizer-BioNTech, Moderna).

Vaccine Adjuvants

Adjuvants are substances added to vaccines to enhance the body's immune response to the provided antigen.

  • Purpose: Increase immunogenicity, reduce the amount of antigen needed, and improve vaccine efficacy.

  • Examples: Aluminum salts (alum) are commonly used adjuvants.

New Vaccine Technologies

Recent advances in biotechnology have led to the development of novel vaccine platforms.

  • mRNA Vaccines: Use messenger RNA to instruct cells to produce antigenic proteins.

  • Viral Vector Vaccines: Use harmless viruses to deliver genetic material encoding antigens.

  • Personalized Vaccines: Tailored to individual genetic profiles or tumor antigens (in cancer immunotherapy).

Vaccine Safety

Vaccine safety is a topic of ongoing research and public discussion.

  • Monitoring: Vaccines undergo rigorous testing in clinical trials and post-marketing surveillance.

  • Controversies: Concerns about side effects and misinformation can affect public confidence, but scientific evidence supports the safety and efficacy of vaccines.

Antibody-Antigen Complexes in Diagnostics and Treatment

Antibody-antigen interactions are central to many immunological diagnostic tests and therapies.

  • Specificity: Antibodies bind specifically to their target antigens, allowing for precise detection.

  • Applications: Used in tests such as ELISA, agglutination, and immunofluorescence, as well as in targeted therapies.

Sensitivity and Specificity in Diagnostic Tests

Diagnostic tests are evaluated based on their sensitivity and specificity.

  • Sensitivity: The ability of a test to correctly identify those with the disease (true positives).

  • Specificity: The ability of a test to correctly identify those without the disease (true negatives).

  • Example of Sensitivity: A highly sensitive HIV test detects nearly all infected individuals.

  • Example of Specificity: A highly specific test for tuberculosis yields few false positives.

Monoclonal Antibodies: Development and Uses

Monoclonal antibodies are laboratory-produced molecules engineered to bind to specific antigens.

  • Development: Produced by hybridoma technology, fusing an antibody-producing B cell with a myeloma cell.

  • Uses: Diagnostic tools (e.g., pregnancy tests, ELISA), therapeutic agents (e.g., cancer, autoimmune diseases).

Agglutination Reactions

Agglutination involves the clumping of particles due to antigen-antibody interactions, useful in diagnostics.

  • Direct Agglutination: Antibodies react with antigens on the surface of cells or particles.

  • Indirect (Passive) Agglutination: Antigens or antibodies are attached to inert particles (e.g., latex beads) to enhance visibility.

  • Hemagglutination: Agglutination of red blood cells, used in blood typing and viral diagnostics.

  • Titer: The concentration of antibodies in serum; a rising titer indicates active infection, while a stable or decreasing titer suggests recovery or past exposure.

Neutralization Reactions

Neutralization tests measure the ability of antibodies to block the biological activity of pathogens or toxins.

  • Application: Used to confirm the presence of specific antibodies (e.g., in viral infections) or to assess vaccine efficacy.

ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA is a sensitive and versatile immunoassay used for detecting and quantifying antigens or antibodies.

  • Benefits: High sensitivity and specificity, quantitative results, suitable for large-scale screening.

  • Direct ELISA: Detects antigens using a labeled primary antibody.

  • Indirect ELISA: Detects antibodies using an antigen-coated surface and a labeled secondary antibody.

Steps in Running an ELISA

  1. Coat wells with antigen (for indirect) or antibody (for direct).

  2. Add sample (serum or antigen).

  3. Add enzyme-linked antibody (direct) or secondary antibody (indirect).

  4. Add substrate; enzyme reaction produces a color change proportional to the amount of antigen or antibody present.

Vaccine Type

Main Feature

Advantages

Disadvantages

Example

Live Attenuated

Weakened pathogen

Strong, long-lasting immunity

Risk for immunocompromised

MMR

Inactivated

Killed pathogen

Safe, stable

Weaker response, boosters needed

IPV

Subunit

Antigenic fragments

Fewer side effects

May need adjuvant

Hepatitis B

Conjugated

Polysaccharide + protein

Effective in children

Complex to produce

Hib

Nucleic Acid

DNA or mRNA

Rapid development

New technology

COVID-19 mRNA

Additional info: This summary expands on the provided learning objectives with academic context, definitions, and examples to ensure a comprehensive, self-contained study guide for microbiology students.

Pearson Logo

Study Prep